SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-008554
Filing Date
2021-04-12
Accepted
2021-04-12 17:00:14
Documents
12
Period of Report
2021-04-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 31388
  Complete submission text file 0001493152-21-008554.txt   208586

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE harrowinccom-20210412.xsd EX-101.SCH 3214
3 XBRL LABEL FILE harrowinccom-20210412_lab.xml EX-101.LAB 35274
4 XBRL PRESENTATION FILE harrowinccom-20210412_pre.xml EX-101.PRE 23157
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3784
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 21821290
SIC: 2834 Pharmaceutical Preparations